Amazon is moving to consolidate its position in the healthcare sector by tapping into the surging demand for GLP-1 weight-loss medications. Through its primary care provider, One Medical, the company has launched the GLP-1 Management Program, a move that signals Amazon’s intent to turn its logistical prowess into a comprehensive clinical service.
The new program is designed as a closed-loop system, integrating virtual and in-person consultations with prescription management and home delivery. By bundling medical oversight with its existing pharmacy infrastructure, Amazon is positioning itself as a more streamlined alternative to traditional healthcare providers and specialized weight-loss startups. The goal is to provide a "longitudinal" care model where the medication is just one component of a broader clinical relationship.
This expansion reflects a broader shift in the retail giant’s healthcare strategy. Having spent years acquiring the necessary components—from the PillPack pharmacy acquisition to the multibillion-dollar purchase of One Medical—Amazon is now layering high-demand services on top of that foundation. In the race to capture the lucrative market for drugs like Ozempic and Wegovy, Amazon’s competitive advantage lies not in the molecules themselves, but in the frictionless delivery of the care surrounding them.
With reporting from NeoFeed.
Source · NeoFeed
